ArticleBiomedicines2024

Long-Acting Injectable Second-Generation Antipsychotics in Seriously Ill Patients with Schizophrenia: Doses, Plasma Levels, and Treatment Outcomes.

Juan José Fernández-Miranda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.